Doan Dao

Prof. Dr. Doan Dao


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2022 in The Lancet Regional Health - Western Pacific
Verified
Journal Article
Open access
TPTrang N.D. Pham
Trang N.D. Pham
DLDuc H. Le
Duc H. Le
DDDiem V.B. Dao
Diem V.B. Dao
LPLoc T.B. Phan
Loc T.B. Phan
TPThuy T.T. Pham
Thuy T.T. Pham
DDDoan Dao
Doan Dao
We conducted a community-based seroprevalence study using three HBV seromarkers (HBsAg, anti-HBs, anti-HBc) in Ho Chi Minh City (HCMC), Vietnam, to (1) determine the prevalence of HBV serologic profiles; (2) document factors associated with HBV infection or susceptibility; and (3) propose strategies toward HBV elimination by 2030. During 2019–2020, we deployed a multistage cluster design with probability proportionate to size, to recruit 20,000 adults for an HBV screening and linkage to care program citywide. Screening results with interpretation, recommendations, and health education materials were returned to participants. Post-study surveys were conducted within three months to identify gaps in linkage to care. Of the 17,600 adults invited, 15,275 (86.7%) participated in the study, 14,674 (96.1%) completing all data for final analyses. The prevalence of HBsAg (+) and HBV-naïve were 7.5% and 37.7%, respectively. HBV vaccination rates were 18.7% and about 50% of HCMC population had been exposed to HBV. Of the persons with HBsAg (+), 27.1% linked to care (76% used health insurance). There were wide variations in HBsAg (+) and HBV vaccination rates between districts, risk factors, and socio-economic statuses. The significant disease burden of and gaps in the continuum of care highlight the need and urgency to address the HBV public health problem in Vietnam. Using three screening seromarkers that tailor interventions to the needs of HBV micro-populations could be an effective strategy to pursue HBV elimination goals. 10.13039/100005564 Gilead Sciences Inc ; 10.13039/100016545 Roche Diagnostic International Ltd ; Roche Diagnostics-Vietnam; Abbott Diagnostics-Vietnam; Hepatitis B Foundation; Medic MedicalCenter, Vietnam; Center of Excellence for Liver Disease in Vietnam, Johns Hopkins University School of Medicine.

11 February 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
APAnnabelle Pan
Annabelle Pan
TTTruong Ngoc Thai
Truong Ngoc Thai
YSYing-Hsiu Su
Ying-Hsiu Su
DDDoan Dao
Doan Dao
Hepatocellular carcinoma (HCC) is among the world’s third most lethal cancers. In resource-limited settings (RLS), up to 70% of HCCs are diagnosed with limited curative treatments at an advanced symptomatic stage. Even when HCC is detected early and resection surgery is offered, the post-operative recurrence rate after resection exceeds 70% in five years, of which about 50% occur within two years of surgery. There are no specific biomarkers addressing the surveillance of HCC recurrence due to the limited sensitivity of the available methods. The primary goal in the early diagnosis and management of HCC is to cure disease and improve survival, respectively. Circulating biomarkers can be used as screening, diagnostic, prognostic, and predictive biomarkers to achieve the primary goal of HCC. In this review, we highlighted key circulating blood- or urine-based HCC biomarkers and considered their potential applications in resource-limited settings, where the unmet medical needs of HCC are disproportionately highly significant.

12 October 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
TNTran Nguyen
Tran Nguyen
TPTrang Pham
Trang Pham
HTHong K Tang
Hong K Tang
LPLoc Phan
Loc Phan
GMGary Mize
Gary Mize
DDDoan Dao
Doan Dao
Objectives Vietnam is an endemic area for hepatitis B virus and hepatitis C virus infection (HBV-HCV), yet its largest city, Ho Chi Minh City (HCMC), has no comprehensive policy to educate, screen, treat and protect healthcare workers (HCWs) from viral hepatitis. We conducted a mixed-methods study to document HBV-HCV infection rates, risk factors, local barriers and opportunities for providing education, screening and medical care for HCWs. Design This mixed-methods study involved an HBV and HCV serological evaluation, knowledge, attitude and practice survey about viral hepatitis and many in-depth interviews. Descriptive statistics and thematic content analysis using inductive and deductive approaches were used. Setting HCMC, Vietnam. Participants HCWs at risk of viral hepatitis exposure at three hospitals in HCMC. Results Of the 210 invited HCWs, 203 were enrolled. Of the 203 HCWs enrolled, 20 were hepatitis B surface antigen-positive, 1 was anti-hepatitis C antibody (anti-HCV Ab)-positive, 57 were anti-hepatitis B core Ab-positive and 152 had adequate anti-hepatitis B surface Ab (anti-HBs Ab) titre (≥10IU/mL). Only 50% of the infected HCWs reported always using gloves during a clinical activity involving handling of blood or bodily fluid. Approximately 50% of HCWs were still not vaccinated against HBV following 1 year of employment. In-depth interviews revealed two major concerns for most interviewees: the need for financial support for HBV-HCV screening and treatment in HCWs and the need for specific HBV-HCV guidelines to be independently developed. Conclusions The high HBV infection rate in HCWs coupled with inadequate preventive occupational practices among the population in HCMC highlight the urgent needs to establish formal policy and rigorous education, screening, vaccination and treatment programmes to protect HCWs from HBV acquisition or to manage those living with chronic HBV in Vietnam.

12 September 2024 in eClinicalMedicine
Verified
Journal Article
Open access
TKThanh Kim
Thanh Kim
TPTrang Ngoc Doan Pham
Trang Ngoc Doan Pham
PPPaul Phan
Paul Phan
Minh H. N. LeMinh H. N. Le
Minh H. N. Le
QLQuan Le
Quan Le
DDDoan Dao
Doan Dao
Expanding chronic hepatitis B (CHB) testing through effective implementation strategies in primary- and community-care setting is crucial for elimination. Our study aimed to determine the effectiveness of all available strategies in the literature and evaluate their specifications and implementation outcomes, thereby informing future programming and policymaking. We conducted a systematic review and meta-analysis (PROSPERO CRD42023455781), searching Scopus, Embase, PubMed, and CINAHL databases up to June 05, 2024, for randomized controlled trials investigating primary- and community-care-based implementation strategies to promote CHB testing. Studies were screened against a priori eligibility criteria, and their data were extracted using a standardized protocol if included. ROB-2 was used to assess the risk of bias. Implementation strategies' components were characterized using the Behavior Change Wheel (BCW) framework. Random-effect models were applied to pool the effectiveness estimate by strategy. Mixed-effect meta-regression was employed to investigate if effectiveness varied by the number of strategy's BCW components. 7146 unique records were identified. 25 studies were eligible for the review, contributing 130,598 participants. 19 studies were included in the meta-analysis. No studies were conducted in low-and-middle-income countries. Implementation outcomes were reported in only ten studies (40%). Community-based strategies included lay health workers-led education (Pooled Risk Difference = 27.9% [95% Confidence Interval = 3.4–52.4], I2 = 99.3%) or crowdsourced education on social media (3.1% [−2.2 to 8.4], 0.0%). Primary care-based strategies consisted of electronic alert system (8.4% [3.7–13.1], 95.0%) and healthcare providers-led education (HCPs, 62.5% [53.1–71.9], 27.5%). The number of BCW-framework-driven strategy components showed a significant dose-response relationship with effectiveness. HCPs-led education stands out, and more enriched multicomponent strategies had better effectiveness. Future implementation strategies should consider critical contextual factors and policies to achieve a sustainable impact towards hepatitis B elimination targets. Tran Dolch Post-Doctoral Fellowship in Hepatology, 10.13039/100012304 Johns Hopkins University School of Medicine , Baltimore MD, USA.

20 December 2021 in Clinical Liver Disease
Verified
Journal Article
Open access
PDF file
TNTran Nguyen
Tran Nguyen
TPTrang Pham
Trang Pham
LPLoc Phan
Loc Phan
GMGary Mize
Gary Mize
ATAmy Trang
Amy Trang
DDDoan Dao
Doan Dao
Content available: Audio Recording

25 March 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NONazli Begum Ozturk
Nazli Begum Ozturk
NBNathanial Bartosek
Nathanial Bartosek
MTMerih Deniz Toruner
Merih Deniz Toruner
AMAymen Mumtaz
Aymen Mumtaz
CSCem Simsek
Cem Simsek
AGAhmet Gurakar
Ahmet Gurakar
Liver transplantation (LT) remains the only curative treatment for end-stage liver disease as well as acute liver failure. With the exponential increase in organ demand due to the increasing incidence and prevalence of liver diseases, the need to overcome the supply and demand mismatch has arisen. In this review, we discuss the current universal status of LT, emphasizing various LT practices worldwide.